Biomarker research

The Cancer Research Group focusses on identification and validation of biomarkers predictive of responsiveness to treatment as well as identification of prognostic markers.

A particular specialism of the laboratory is glycoproteomics. We have developed methods for medium-throughput screening of biomarkers from body fluids and tissues.

The availability of plasma, serum and urine samples and DNA collected through the DietCompLyf study allows the comparison between samples from patients with different clinical outcome. Tissue samples from breast cancer patients allow validation of the markers detected in serum and other bodily fluids.

Studies are taken in collaboration with our partners.

Diet CompLyf logo.

Diet and Lifestyle research

has been funded by Against Breast Cancer registered charity number (1121258). Find out more about Diet and Lifestyle research.



Contact us to find out more about our research.